NCT02764567

Brief Summary

Lab sampling for clinical trial participants can be a stressful and painful experience. Most trial participants will have blood drawn for lab samples at multiple study visits. The participants must fast for up to ten hours before the blood sampling, in many cases, and patients often report a painful experience if more than one venipuncture occurs. In addition, the number of collection tubes can increase the anxiety level of the patient and the phlebotomist. This project proposes to evaluate if essential oil aromatherapy results in less pain and /or anxiety when compared to usual care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 2, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 6, 2016

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

February 27, 2018

Status Verified

February 1, 2018

Enrollment Period

1.6 years

First QC Date

May 2, 2016

Last Update Submit

February 23, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Pain Scores

    At the time of study enrollment and again upon completion at 6 months

  • Change in Anxiety Scores

    At the time of study enrollment and again upon completion at 6 months

Secondary Outcomes (2)

  • Number of venipunctures needed to collect required sample

    At the time of study completion at 6 months

  • Number of blood collection tubes required for sample

    At the time of study completion at 6 months

Study Arms (2)

Aromatherapy

EXPERIMENTAL

The participants randomized to aromatherapy will be offered one of three essential oils, 'applied' to their smell zone via cotton ball that are known to have anti-anxiety effect. These are: * ginger * calming * lavender The participant's choice will be documented in a database. The participant can chose an oil each time (i.e., they are not bound to use only the first choice oil). Pain and anxiety will be measured prior to receiving the essential oils and again after the phlebotomy procedure. Blood pressure and pulse will also be measured post-phlebotomy.

Other: Essential Oil

Standard of Care

NO INTERVENTION

The participants randomized to standard of care will proceed to the outpatient phlebotomy room in the Heart Care Clinic as per usual care. Pain, anxiety, blood pressure and pulse will be assessed pre and post-procedure.

Interventions

Participants in this arm will be offered one of three essential oils: ginger, lavender or calming

Aromatherapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be at least 18 years of age
  • Must be currently participating in a clinical trial at HealthEast

You may not qualify if:

  • Known allergy to any of the oils used for aromatherapy
  • Less than age 18
  • Declined to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HealthEast Clinical Trials Office

Saint Paul, Minnesota, 55104, United States

Location

Related Links

MeSH Terms

Interventions

Oils, Volatile

Intervention Hierarchy (Ancestors)

OilsLipids

Study Officials

  • Beth Jorgeonson, RN, BSN

    HealthEast Care System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2016

First Posted

May 6, 2016

Study Start

May 1, 2016

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

February 27, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Study results will be shared with the organization and submitted for publication. Individual participant data will not be shared.

Locations